A review in Genes & Diseases highlights how
lactate, a molecule long associated with energy metabolism, may influence heart damage and repair after blood flow is restored following a heart attack. The article examines
lactylation, a chemical modification of proteins that connects metabolic changes with gene activity and cell survival.
Prepared by a team from China Three Gorges University, Yichang Central People's Hospital and Huangshi Central Hospital, the review focuses on
myocardial ischemia–reperfusion injury. Restoring circulation is essential for rescuing oxygen-starved heart muscle, but the return of blood flow can also trigger oxidative stress, inflammation and additional cellular damage.
Lactate sits at the intersection of these processes. It serves as a fuel for the heart and also contributes to signaling. When oxygen availability falls, altered metabolism and impaired clearance can cause lactate to accumulate, changing the environment in which cardiac cells function.
Through lactylation, lactate-related groups are added to proteins, including
histones, which help package DNA and regulate gene activity. These modifications can influence how cells respond to injury, linking their metabolic state with the programs that govern damage, survival and repair.
The review emphasizes that lactylation has a
dual role. Some modifications can activate repair-associated genes, reduce inflammation and support new blood vessel formation. Others may contribute to scarring or worsen injury. The outcome depends on the proteins modified, the cell types involved and the stage of disease.
The article also explores connections with cell death mechanisms. These include
apoptosis, the controlled dismantling of cells;
pyroptosis, an inflammatory form of cell death;
ferroptosis, driven by iron-dependent damage to membrane fats; and
autophagy, the cellular recycling process that can support survival or contribute to death.
Lactylation interacts with other molecular modifications, including acetylation, phosphorylation and methylation. This overlap creates a regulatory network and makes it difficult to isolate the effects of any single pathway.
Potential treatment targets include
lactate dehydrogenase A, which helps generate lactate,
monocarboxylate transporters that move it across cell membranes, and enzymes that add or remove lactylation marks. Adjusting these processes could offer ways to limit injury while preserving beneficial repair responses.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 10.4 |Impact Factor:14.6
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available
online in
ScienceDirect (
https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to
Genes & Diseases may be made using
Editorial Manager (
https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (
https://x.com/GenesNDiseases)
# # # # # #
Reference
Xiaoting Yang, Hui Wu, Di Liu, Gang Zhou, Dong Zhang, Yanfang Liu, Yi Li, Tian Zhou, Yan Xiong, Lactylation: Metabolic epigenetic regulation and cell death mechanisms in myocardial ischemia‒reperfusion injury, Genes & Diseases, Volume 14, Issue 1, 2027, 102211,
https://doi.org/10.1016/j.gendis.2026.102211
Funding
National Natural Science Foundation of China
82170260